Economia

Athenahealth, Inc. (NASDAQ:ATHN) Sees Unusual Volume Mid-Session

Athenahealth, Inc. (NASDAQ:ATHN) Sees Unusual Volume Mid-Session

Canaccord Genuity reaffirmed a "hold" rating and set a $112.00 price target on shares of athenahealth in a report on Monday, February 6th. Cantor Fitzgerald assumed coverage on athenahealth in a research note on Thursday, January 5th.

4/4/2017-Piper Jaffray Companies Reiterated Rating of Overweight. The company now has an average rating of "Hold" and an average price target of $129.32.

Athenahealth's shares jumped 15.7 percent to $123 in trading before the bell.

ILLEGAL ACTIVITY WARNING: "Insider Selling: athenahealth, Inc (ATHN) CEO Sells 8,000 Shares of Stock" was first published by Transcript Daily and is owned by of Transcript Daily.

The firm has a 50-day moving average of $110.87 and a 200 day moving average of $110.59. The business's revenue was up 11.4% on a year-over-year basis. On average, analysts anticipate that athenahealth, Inc will post $1.89 EPS for the current fiscal year.

The current consensus rating on athenahealth (NASDAQ:ATHN) is Buy (Score: 2.52) with a consensus target price of $131.42 per share, a potential 1.04% upside. If you are accessing this news story on another site, it was illegally copied and reposted in violation of global trademark & copyright legislation. Advisor Group Inc. increased its position in athenahealth by 13.8% in the third quarter. Also, CEO Jonathan Bush sold 8,000 shares of athenahealth stock in a transaction on Tuesday, April 25th. If the share price is now hovering near the 52 week low and the value is achieved in the current past then it can suggest that the price of the shares is likely to go up. Following the transaction, the chief executive officer now owns 319,807 shares in the company, valued at $38,376,840. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

In related news, SVP Jonathan D. Porter sold 300 shares of athenahealth stock in a transaction on Monday, May 15th.

On 12/15/2016 Amy Abernethy, Director, sold 1,000 with an average share price of $117.15 per share and the total transaction amounting to $117,150.00. The disclosure for this sale can be found here.

Elliott is a $33-billion multi-strategy hedge fund and an aggressive activist investor, launching more activist campaigns than any other hedge fund in the last few years. FNY Partners Fund LP boosted its position in athenahealth by 1,900.0% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider's stock valued at $180,286,000 after buying an additional 1,594,643 shares during the last quarter.

Investment firm Elliott Associates has bought 9.2 percent of athenahealth stock, according to an SEC filing submitted Tuesday, and speculation has already started about what that might mean for the health IT company's future. UBS Asset Management Americas Inc. raised its position in athenahealth by 7.2% in the third quarter. State Street Corp now owns 502,823 shares of the health services provider's stock valued at $56,662,000 after buying an additional 17,718 shares during the period. Russell Investments Group Ltd. acquired a new stake in shares of athenahealth during the fourth quarter valued at about $118,000.